Marc Beer holds over 25 years as an entrepreneur in the pharmaceutical sales and marketing industry, during which time he has been involved with quite a significant number of firms. Throughout this time, he has become well-known within the niche, with this primarily being driven by the creative and unique solutions that he’s developed to help lead firms to success.
After graduating from Miami University in 1987 with a Bachelor of Science in Business, Beer soon found himself working for Genzyme, where he predominantly served in its sales and marketing division. In the years following this, he was able to create a positive name for himself, which subsequently led to a variety of promotions. These eventually led to Beer being named the Vice President of Global Marketing at the company, which allowed him to have a significant hand in many of its operations.
During this time, he had developed a large interest in establishing a firm of his own. As time wore on, he soon realized that he could no longer ignore this urge, which eventually led to him departing Genzyme and founding ViaCell in 2000. Despite the significant risk that was involved in creating the company, Marc Beer would soon achieve a great degree of success with it.
As a result, the biotechnology company soon grew to employ over 300 people and was eventually listed on the NASDAQ. Throughout this time, the firm specialized in umbilical cord blood stem cell collection and preservation, with a focus on using them to treat various conditions. Eventually, this led to the company being sold for $300 million to PerkinElmer. Learn more: https://renoviainc.com/leadership/
Following this, tragedy would strike Marc Beer, as his wife would suffer from a pulmonary embolism that would claim her life. As a result, Beer took time away from his career to concentrate on his family and care for his three young children. Over time, however, his children would persuade him to get back into his entrepreneurial endeavors, which he eventually did.
In the years following this, Beer would begin working with a variety of organizations, with each of these see a large amount of success. In 2016, he would go on to create Renovia Inc, a firm that specializes in creating diagnostic and treatment tools for women who suffer from pelvic floor disorders. The company would subsequently go on to achieve a significant amount of success, with 2018 being quite an important year for Renovia, with this being for a few notable reasons.
The first of these is that the company was able to release its Leva device, which received approval from the Food and Drug Administration (FDA) in April of that year. Alongside this, Beer was able to lead the company through a Series B investment round that attracted $32 million in funding. Alongside this, the company would receive $10 million in venture funding.
Throughout this time, Marc Beer was able to attract investments from a variety of organizations, including The Longwood Fund, Ascension Ventures, and Perceptive Advisors, among several others. With the funding, the firm looks to release several other devices in the coming years.